Taiwan FDA registration fa474d37020bf21a859852b72e5913c3
Apex multiple drug concentration semi-quantitative correction solution
TW: 亞培多重藥物濃度半定量校正液
Taiwan·Risk Class 2·MICROGENICS CORPORATION·Registered Nov 02, 2020 – Nov 02, 2025ExpiredRegistration details
- Analysis ID
- fa474d37020bf21a859852b72e5913c3
- Customs Code
- DHA05603369903
Company information
- Manufacturer
- MICROGENICS CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product is used to correct the Apex diazo base salt serum test set and the Apex tricyclic antidepressant test set on the Alinity c analyzer.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3200 Clinical Toxicology Corrector
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Nov 02, 2020
- Expiry Date
- Nov 02, 2025
About this record
Access comprehensive regulatory information for Apex multiple drug concentration semi-quantitative correction solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fa474d37020bf21a859852b72e5913c3 and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices